220 related articles for article (PubMed ID: 28930757)
1. High Expression of CCR7 Predicts Lymph Node Metastasis and Good Prognosis in Triple Negative Breast Cancer.
Li X; Sun S; Li N; Gao J; Yu J; Zhao J; Li M; Zhao Z
Cell Physiol Biochem; 2017; 43(2):531-539. PubMed ID: 28930757
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated eIF2α predicts disease-free survival in triple-negative breast cancer patients.
Guo L; Chi Y; Xue J; Ma L; Shao Z; Wu J
Sci Rep; 2017 Mar; 7():44674. PubMed ID: 28294178
[TBL] [Abstract][Full Text] [Related]
3. CC-Chemokine receptor CCR7: a key molecule for lymph node metastasis in esophageal squamous cell carcinoma.
Irino T; Takeuchi H; Matsuda S; Saikawa Y; Kawakubo H; Wada N; Takahashi T; Nakamura R; Fukuda K; Omori T; Kitagawa Y
BMC Cancer; 2014 Apr; 14():291. PubMed ID: 24766770
[TBL] [Abstract][Full Text] [Related]
4. Novel genes associated with lymph node metastasis in triple negative breast cancer.
Mathe A; Wong-Brown M; Morten B; Forbes JF; Braye SG; Avery-Kiejda KA; Scott RJ
Sci Rep; 2015 Nov; 5():15832. PubMed ID: 26537449
[TBL] [Abstract][Full Text] [Related]
5. Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer.
Kodama J; Hasengaowa ; Kusumoto T; Seki N; Matsuo T; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y
Ann Oncol; 2007 Jan; 18(1):70-76. PubMed ID: 17032700
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis.
Takanami I
Int J Cancer; 2003 Jun; 105(2):186-9. PubMed ID: 12673677
[TBL] [Abstract][Full Text] [Related]
7. CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer.
Arigami T; Natsugoe S; Uenosono Y; Yanagita S; Arima H; Hirata M; Ishigami S; Aikou T
Int J Oncol; 2009 Jul; 35(1):19-24. PubMed ID: 19513547
[TBL] [Abstract][Full Text] [Related]
8. Differential roles of Bcl2L12 and its short variant in breast cancer lymph node metastasis.
Chien ST; Yang TF; Yang MC; Hsu CM; Hong YR; Lee TM
Oncol Rep; 2015 Aug; 34(2):961-71. PubMed ID: 26082034
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of HABP1 is a novel prognostic indicator in triple-negative breast cancers.
Wang J; Song Y; Liu T; Shi Q; Zhong Z; Wei W; Huang S; Pang D
Tumour Biol; 2015 Jun; 36(6):4793-9. PubMed ID: 25794640
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer.
Chung SY; Jung YY; Park IA; Kim H; Chung YR; Kim JY; Park SY; Im SA; Lee KH; Moon HG; Noh DY; Han W; Lee C; Kim TY; Ryu HS
Clin Exp Metastasis; 2016 Feb; 33(2):179-85. PubMed ID: 26585892
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.
Gasparini P; Fassan M; Cascione L; Guler G; Balci S; Irkkan C; Paisie C; Lovat F; Morrison C; Zhang J; Scarpa A; Croce CM; Shapiro CL; Huebner K
PLoS One; 2014; 9(2):e88525. PubMed ID: 24505496
[TBL] [Abstract][Full Text] [Related]
12. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
Ma F; Ding X; Fan Y; Ying J; Zheng S; Lu N; Xu B
PLoS One; 2014; 9(11):e112765. PubMed ID: 25393310
[TBL] [Abstract][Full Text] [Related]
13. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer.
Cabioglu N; Yazici MS; Arun B; Broglio KR; Hortobagyi GN; Price JE; Sahin A
Clin Cancer Res; 2005 Aug; 11(16):5686-93. PubMed ID: 16115904
[TBL] [Abstract][Full Text] [Related]
14. CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis.
Wu J; Li L; Liu J; Wang Y; Wang Z; Wang Y; Liu W; Zhou Z; Chen C; Liu R; Yang R
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):835-842. PubMed ID: 30032244
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
Urru SAM; Gallus S; Bosetti C; Moi T; Medda R; Sollai E; Murgia A; Sanges F; Pira G; Manca A; Palmas D; Floris M; Asunis AM; Atzori F; Carru C; D'Incalci M; Ghiani M; Marras V; Onnis D; Santona MC; Sarobba G; Valle E; Canu L; Cossu S; Bulfone A; Rocca PC; De Miglio MR; Orrù S
BMC Cancer; 2018 Jan; 18(1):56. PubMed ID: 29310602
[TBL] [Abstract][Full Text] [Related]
16. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis.
Liu Y; Ji R; Li J; Gu Q; Zhao X; Sun T; Wang J; Li J; Du Q; Sun B
J Exp Clin Cancer Res; 2010 Feb; 29(1):16. PubMed ID: 20181250
[TBL] [Abstract][Full Text] [Related]
17. Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in squamous cell carcinoma of the tongue.
Al-Shareef H; Hiraoka SI; Tanaka N; Shogen Y; Lee AD; Bakhshishayan S; Kogo M
Oncol Rep; 2016 Nov; 36(5):2444-2454. PubMed ID: 27666723
[TBL] [Abstract][Full Text] [Related]
18. CCR7 expression and intratumoral FOXP3+ regulatory T cells are correlated with overall survival and lymph node metastasis in gastric cancer.
Zhou S; Shen Z; Wang Y; Ma H; Xu S; Qin J; Chen L; Tao H; Zhen Z; Chen G; Zhang Z; Li R; Xiao H; Zhong C; Yang Y; Liang C
PLoS One; 2013; 8(9):e74430. PubMed ID: 24040244
[TBL] [Abstract][Full Text] [Related]
19. Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer.
Nakata B; Fukunaga S; Noda E; Amano R; Yamada N; Hirakawa K
Oncology; 2008; 74(1-2):69-75. PubMed ID: 18544997
[TBL] [Abstract][Full Text] [Related]
20. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma.
Wagner PL; Moo TA; Arora N; Liu YF; Zarnegar R; Scognamiglio T; Fahey TJ
Ann Surg Oncol; 2008 Oct; 15(10):2833-41. PubMed ID: 18696160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
